BioQL Invest ApS: Financial statements 2025
CVR: 37755001
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BioQL Invest ApS (CVR 37755001) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -9,737 and a net result of DKK -7,949 compared with DKK -4,372 the year before. Equity in the 2025 report amounted to DKK 70,917. The solvency ratio was 89%.
- Gross Profit
- DKK -9,737
- Profit/Loss
- DKK -7,949
- Equity
- DKK 70,917
- Total Assets
- DKK 79,667
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -10K | -8K | 71K | 0 |
| 2024 | - | -8K | -4K | 79K | - |
| 2023 | - | -8K | 2.6M | 153K | - |
| 2022 | - | -8K | 6.5M | 6.7M | - |
| 2021 | - | -13K | 6.5M | 6.6M | - |
Official annual report
How creditworthy is BioQL Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BioQL Invest ApS has published its annual report for 2024. Gross profit came to DKK -8,125, and the net result was DKK -4,372.
About BioQL Invest ApS
BioQL Invest ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2016. The company is registered under the industry Investering for egen regning. The management consists of Mads Bredning Rydahl and Thomas Michael Redder Laursen. The company is owned by TMRL Holding ApS and Rydahl Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -9,737 and a net result of DKK -7,949 compared with DKK -4,372 the year before. Equity in the 2025 report amounted to DKK 70,917.